FemmePharma Global Healthcare, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1996-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://femmepharma.com
Clinical Trials
3
Active:0
Completed:3
Trial Phases
1 Phases
Phase 2:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 2
3 (100.0%)An Open-Label, MultiCenter Evaluation of the Use of Topically Administered FP1198 in Subjects With Pain Associated With Cyclic Mastalgia
Phase 2
Completed
- Conditions
- Moderate to Severe Cyclic Mastalgia
- First Posted Date
- 2010-04-16
- Last Posted Date
- 2011-10-26
- Lead Sponsor
- FemmePharma Global Healthcare, Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT01105793
- Locations
- 🇺🇸
Women's Health Care, San Diego, California, United States
🇺🇸Horizons Clinical Research, Denver, Colorado, United States
🇺🇸Kentucky Medical Research Center, Lexington, Kentucky, United States
A Study of Oxybutynin for the Treatment of Urge Urinary Incontinence
- First Posted Date
- 2008-09-09
- Last Posted Date
- 2009-10-15
- Lead Sponsor
- FemmePharma Global Healthcare, Inc.
- Target Recruit Count
- 45
- Registration Number
- NCT00749632
- Locations
- 🇺🇸
SNBL Clinical Pharmacology Center, Baltimore, Maryland, United States
🇺🇸Advanced Biomedical Research, Hackensack, New Jersey, United States
A Study of Topical Danazol for the Treatment of Pain Associated With Fibrocystic Breast Disease
- First Posted Date
- 2008-08-29
- Last Posted Date
- 2010-05-27
- Lead Sponsor
- FemmePharma Global Healthcare, Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT00744276
- Locations
- 🇺🇸
Women's Health Research, Phoenix, Arizona, United States
🇺🇸Advanced Clinical Therapeutics, LLC, Tucson, Arizona, United States
🇺🇸Impact Clinical Trials, Las Vegas, Nevada, United States
News
No news found